000 01441 a2200373 4500
005 20250518012959.0
264 0 _c20200227
008 202002s 0 0 eng d
022 _a1945-7197
024 7 _a10.1210/jc.2018-02236
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLyu, Houchen
245 0 0 _aComparison of Denosumab and Bisphosphonates in Patients With Osteoporosis: A Meta-Analysis of Randomized Controlled Trials.
_h[electronic resource]
260 _bThe Journal of clinical endocrinology and metabolism
_c05 2019
300 _a1753-1765 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural
650 0 4 _aBone Density Conservation Agents
_xtherapeutic use
650 0 4 _aDenosumab
_xtherapeutic use
650 0 4 _aDiphosphonates
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aOsteoporosis
_xdrug therapy
650 0 4 _aPrognosis
650 0 4 _aRandomized Controlled Trials as Topic
700 1 _aJundi, Bakr
700 1 _aXu, Chang
700 1 _aTedeschi, Sara K
700 1 _aYoshida, Kazuki
700 1 _aZhao, Sizheng
700 1 _aNigwekar, Sagar U
700 1 _aLeder, Benjamin Z
700 1 _aSolomon, Daniel H
773 0 _tThe Journal of clinical endocrinology and metabolism
_gvol. 104
_gno. 5
_gp. 1753-1765
856 4 0 _uhttps://doi.org/10.1210/jc.2018-02236
_zAvailable from publisher's website
999 _c29148487
_d29148487